nodes	percent_of_prediction	percent_of_DWPC	metapath
Diclofenamide—CYP2C9—Nilutamide—prostate cancer	0.0949	0.294	CbGbCtD
Diclofenamide—CYP2C9—Bicalutamide—prostate cancer	0.0949	0.294	CbGbCtD
Diclofenamide—CYP2C9—Estrone—prostate cancer	0.0569	0.176	CbGbCtD
Diclofenamide—CYP2C9—Capecitabine—prostate cancer	0.0431	0.134	CbGbCtD
Diclofenamide—CYP2C9—Estradiol—prostate cancer	0.0327	0.101	CbGbCtD
Diclofenamide—Quinethazone—SLC12A2—prostate cancer	0.00749	1	CrCbGaD
Diclofenamide—CA14—prostate gland—prostate cancer	0.00673	0.0892	CbGeAlD
Diclofenamide—CYP2C9—urine—prostate cancer	0.00635	0.0841	CbGeAlD
Diclofenamide—CA14—seminal vesicle—prostate cancer	0.00569	0.0754	CbGeAlD
Diclofenamide—CA7—renal system—prostate cancer	0.0055	0.073	CbGeAlD
Diclofenamide—CA5B—prostate gland—prostate cancer	0.00471	0.0624	CbGeAlD
Diclofenamide—CA12—renal system—prostate cancer	0.00358	0.0474	CbGeAlD
Diclofenamide—CA4—prostate gland—prostate cancer	0.00325	0.0431	CbGeAlD
Diclofenamide—CA5B—urethra—prostate cancer	0.00315	0.0418	CbGeAlD
Diclofenamide—CA9—testis—prostate cancer	0.00312	0.0414	CbGeAlD
Diclofenamide—CA1—renal system—prostate cancer	0.00283	0.0375	CbGeAlD
Diclofenamide—CA4—seminal vesicle—prostate cancer	0.00275	0.0364	CbGeAlD
Diclofenamide—CA2—prostate gland—prostate cancer	0.00269	0.0357	CbGeAlD
Diclofenamide—CA2—seminal vesicle—prostate cancer	0.00228	0.0302	CbGeAlD
Diclofenamide—CA4—renal system—prostate cancer	0.00221	0.0293	CbGeAlD
Diclofenamide—CA4—urethra—prostate cancer	0.00218	0.0288	CbGeAlD
Diclofenamide—CA1—bone marrow—prostate cancer	0.00214	0.0284	CbGeAlD
Diclofenamide—CA5B—testis—prostate cancer	0.00207	0.0275	CbGeAlD
Diclofenamide—CA2—epithelium—prostate cancer	0.00198	0.0262	CbGeAlD
Diclofenamide—CA2—renal system—prostate cancer	0.00184	0.0243	CbGeAlD
Diclofenamide—CA4—bone marrow—prostate cancer	0.00167	0.0222	CbGeAlD
Diclofenamide—CA5B—lymph node—prostate cancer	0.0015	0.0199	CbGeAlD
Diclofenamide—CA4—testis—prostate cancer	0.00143	0.019	CbGeAlD
Diclofenamide—CA2—bone marrow—prostate cancer	0.00139	0.0184	CbGeAlD
Diclofenamide—CA1—lymph node—prostate cancer	0.00133	0.0176	CbGeAlD
Diclofenamide—CA2—testis—prostate cancer	0.00119	0.0157	CbGeAlD
Diclofenamide—CA4—lymph node—prostate cancer	0.00104	0.0137	CbGeAlD
Diclofenamide—Hepatic failure—Capecitabine—prostate cancer	0.000902	0.0024	CcSEcCtD
Diclofenamide—Headache—Degarelix—prostate cancer	0.000898	0.00239	CcSEcCtD
Diclofenamide—Nausea—Estradiol valerate/Dienogest—prostate cancer	0.000896	0.00239	CcSEcCtD
Diclofenamide—Dizziness—Cabazitaxel—prostate cancer	0.000893	0.00238	CcSEcCtD
Diclofenamide—Leukopenia—Goserelin—prostate cancer	0.000884	0.00236	CcSEcCtD
Diclofenamide—Agranulocytosis—Mitoxantrone—prostate cancer	0.000871	0.00232	CcSEcCtD
Diclofenamide—CA2—lymph node—prostate cancer	0.00086	0.0114	CbGeAlD
Diclofenamide—Vomiting—Cabazitaxel—prostate cancer	0.000859	0.00229	CcSEcCtD
Diclofenamide—Nausea—Degarelix—prostate cancer	0.000852	0.00227	CcSEcCtD
Diclofenamide—Headache—Cabazitaxel—prostate cancer	0.000846	0.00226	CcSEcCtD
Diclofenamide—Gastrointestinal disorder—Ethinyl Estradiol—prostate cancer	0.000846	0.00225	CcSEcCtD
Diclofenamide—Fatigue—Ethinyl Estradiol—prostate cancer	0.000844	0.00225	CcSEcCtD
Diclofenamide—Hyperuricaemia—Epirubicin—prostate cancer	0.000839	0.00224	CcSEcCtD
Diclofenamide—Tinnitus—Estradiol—prostate cancer	0.000839	0.00224	CcSEcCtD
Diclofenamide—Constipation—Ethinyl Estradiol—prostate cancer	0.000838	0.00223	CcSEcCtD
Diclofenamide—Asthenia—Bicalutamide—prostate cancer	0.000831	0.00222	CcSEcCtD
Diclofenamide—Pruritus—Bicalutamide—prostate cancer	0.00082	0.00219	CcSEcCtD
Diclofenamide—Confusional state—Goserelin—prostate cancer	0.000813	0.00217	CcSEcCtD
Diclofenamide—Feeling abnormal—Ethinyl Estradiol—prostate cancer	0.000807	0.00215	CcSEcCtD
Diclofenamide—Nausea—Cabazitaxel—prostate cancer	0.000802	0.00214	CcSEcCtD
Diclofenamide—Blood uric acid increased—Epirubicin—prostate cancer	0.000792	0.00211	CcSEcCtD
Diclofenamide—Thrombocytopenia—Goserelin—prostate cancer	0.000789	0.0021	CcSEcCtD
Diclofenamide—Ataxia—Docetaxel—prostate cancer	0.000787	0.0021	CcSEcCtD
Diclofenamide—Hyperuricaemia—Doxorubicin—prostate cancer	0.000776	0.00207	CcSEcCtD
Diclofenamide—Body temperature increased—Ethinyl Estradiol—prostate cancer	0.000774	0.00206	CcSEcCtD
Diclofenamide—Anorexia—Goserelin—prostate cancer	0.000768	0.00205	CcSEcCtD
Diclofenamide—Tension—Estradiol—prostate cancer	0.000768	0.00205	CcSEcCtD
Diclofenamide—Dizziness—Bicalutamide—prostate cancer	0.000766	0.00204	CcSEcCtD
Diclofenamide—Ataxia—Capecitabine—prostate cancer	0.000762	0.00203	CcSEcCtD
Diclofenamide—Anorexia—Conjugated Estrogens—prostate cancer	0.000761	0.00203	CcSEcCtD
Diclofenamide—Nervousness—Estradiol—prostate cancer	0.000761	0.00203	CcSEcCtD
Diclofenamide—Hypokalaemia—Capecitabine—prostate cancer	0.000738	0.00197	CcSEcCtD
Diclofenamide—Vomiting—Bicalutamide—prostate cancer	0.000737	0.00196	CcSEcCtD
Diclofenamide—Tremor—Estradiol—prostate cancer	0.000734	0.00196	CcSEcCtD
Diclofenamide—Blood uric acid increased—Doxorubicin—prostate cancer	0.000733	0.00195	CcSEcCtD
Diclofenamide—Rash—Bicalutamide—prostate cancer	0.000731	0.00195	CcSEcCtD
Diclofenamide—Headache—Bicalutamide—prostate cancer	0.000726	0.00193	CcSEcCtD
Diclofenamide—Agranulocytosis—Etoposide—prostate cancer	0.000725	0.00193	CcSEcCtD
Diclofenamide—Paraesthesia—Goserelin—prostate cancer	0.000724	0.00193	CcSEcCtD
Diclofenamide—Paraesthesia—Conjugated Estrogens—prostate cancer	0.000717	0.00191	CcSEcCtD
Diclofenamide—Somnolence—Goserelin—prostate cancer	0.000717	0.00191	CcSEcCtD
Diclofenamide—Somnolence—Conjugated Estrogens—prostate cancer	0.00071	0.00189	CcSEcCtD
Diclofenamide—Dyspepsia—Goserelin—prostate cancer	0.00071	0.00189	CcSEcCtD
Diclofenamide—Dyspepsia—Conjugated Estrogens—prostate cancer	0.000703	0.00187	CcSEcCtD
Diclofenamide—Asthenia—Ethinyl Estradiol—prostate cancer	0.000703	0.00187	CcSEcCtD
Diclofenamide—Decreased appetite—Goserelin—prostate cancer	0.000701	0.00187	CcSEcCtD
Diclofenamide—Fatigue—Goserelin—prostate cancer	0.000695	0.00185	CcSEcCtD
Diclofenamide—Decreased appetite—Conjugated Estrogens—prostate cancer	0.000694	0.00185	CcSEcCtD
Diclofenamide—Pruritus—Ethinyl Estradiol—prostate cancer	0.000693	0.00185	CcSEcCtD
Diclofenamide—Gastrointestinal disorder—Conjugated Estrogens—prostate cancer	0.000689	0.00184	CcSEcCtD
Diclofenamide—Constipation—Goserelin—prostate cancer	0.000689	0.00184	CcSEcCtD
Diclofenamide—Fatigue—Conjugated Estrogens—prostate cancer	0.000688	0.00183	CcSEcCtD
Diclofenamide—Nausea—Bicalutamide—prostate cancer	0.000688	0.00183	CcSEcCtD
Diclofenamide—Constipation—Conjugated Estrogens—prostate cancer	0.000683	0.00182	CcSEcCtD
Diclofenamide—Feeling abnormal—Goserelin—prostate cancer	0.000664	0.00177	CcSEcCtD
Diclofenamide—Hypokalaemia—Prednisone—prostate cancer	0.000657	0.00175	CcSEcCtD
Diclofenamide—Weight decreased—Docetaxel—prostate cancer	0.000655	0.00175	CcSEcCtD
Diclofenamide—Leukopenia—Mitoxantrone—prostate cancer	0.000653	0.00174	CcSEcCtD
Diclofenamide—Dizziness—Ethinyl Estradiol—prostate cancer	0.000648	0.00173	CcSEcCtD
Diclofenamide—Confusional state—Estradiol—prostate cancer	0.000644	0.00172	CcSEcCtD
Diclofenamide—Body temperature increased—Goserelin—prostate cancer	0.000637	0.0017	CcSEcCtD
Diclofenamide—Weight decreased—Capecitabine—prostate cancer	0.000634	0.00169	CcSEcCtD
Diclofenamide—Body temperature increased—Conjugated Estrogens—prostate cancer	0.000631	0.00168	CcSEcCtD
Diclofenamide—Hepatic failure—Epirubicin—prostate cancer	0.000629	0.00168	CcSEcCtD
Diclofenamide—Vomiting—Ethinyl Estradiol—prostate cancer	0.000623	0.00166	CcSEcCtD
Diclofenamide—Rash—Ethinyl Estradiol—prostate cancer	0.000618	0.00165	CcSEcCtD
Diclofenamide—Headache—Ethinyl Estradiol—prostate cancer	0.000614	0.00164	CcSEcCtD
Diclofenamide—Agranulocytosis—Docetaxel—prostate cancer	0.000602	0.00161	CcSEcCtD
Diclofenamide—Confusional state—Mitoxantrone—prostate cancer	0.0006	0.0016	CcSEcCtD
Diclofenamide—Agranulocytosis—Capecitabine—prostate cancer	0.000583	0.00155	CcSEcCtD
Diclofenamide—Thrombocytopenia—Mitoxantrone—prostate cancer	0.000583	0.00155	CcSEcCtD
Diclofenamide—Nausea—Ethinyl Estradiol—prostate cancer	0.000582	0.00155	CcSEcCtD
Diclofenamide—Hepatic failure—Doxorubicin—prostate cancer	0.000582	0.00155	CcSEcCtD
Diclofenamide—Asthenia—Goserelin—prostate cancer	0.000578	0.00154	CcSEcCtD
Diclofenamide—Paraesthesia—Estradiol—prostate cancer	0.000574	0.00153	CcSEcCtD
Diclofenamide—Asthenia—Conjugated Estrogens—prostate cancer	0.000573	0.00153	CcSEcCtD
Diclofenamide—Pruritus—Goserelin—prostate cancer	0.00057	0.00152	CcSEcCtD
Diclofenamide—Somnolence—Estradiol—prostate cancer	0.000568	0.00151	CcSEcCtD
Diclofenamide—Anorexia—Mitoxantrone—prostate cancer	0.000568	0.00151	CcSEcCtD
Diclofenamide—Pruritus—Conjugated Estrogens—prostate cancer	0.000565	0.00151	CcSEcCtD
Diclofenamide—Weight decreased—Prednisone—prostate cancer	0.000565	0.00151	CcSEcCtD
Diclofenamide—Dyspepsia—Estradiol—prostate cancer	0.000563	0.0015	CcSEcCtD
Diclofenamide—Decreased appetite—Estradiol—prostate cancer	0.000556	0.00148	CcSEcCtD
Diclofenamide—Gastrointestinal disorder—Estradiol—prostate cancer	0.000552	0.00147	CcSEcCtD
Diclofenamide—Fatigue—Estradiol—prostate cancer	0.000551	0.00147	CcSEcCtD
Diclofenamide—Constipation—Estradiol—prostate cancer	0.000546	0.00146	CcSEcCtD
Diclofenamide—Leukopenia—Etoposide—prostate cancer	0.000543	0.00145	CcSEcCtD
Diclofenamide—Paraesthesia—Mitoxantrone—prostate cancer	0.000535	0.00142	CcSEcCtD
Diclofenamide—Dizziness—Goserelin—prostate cancer	0.000533	0.00142	CcSEcCtD
Diclofenamide—Ataxia—Epirubicin—prostate cancer	0.000531	0.00142	CcSEcCtD
Diclofenamide—Somnolence—Mitoxantrone—prostate cancer	0.000529	0.00141	CcSEcCtD
Diclofenamide—Dizziness—Conjugated Estrogens—prostate cancer	0.000528	0.00141	CcSEcCtD
Diclofenamide—Feeling abnormal—Estradiol—prostate cancer	0.000527	0.0014	CcSEcCtD
Diclofenamide—Dyspepsia—Mitoxantrone—prostate cancer	0.000524	0.0014	CcSEcCtD
Diclofenamide—Tinnitus—Capecitabine—prostate cancer	0.000523	0.00139	CcSEcCtD
Diclofenamide—Decreased appetite—Mitoxantrone—prostate cancer	0.000518	0.00138	CcSEcCtD
Diclofenamide—Hypokalaemia—Epirubicin—prostate cancer	0.000514	0.00137	CcSEcCtD
Diclofenamide—Fatigue—Mitoxantrone—prostate cancer	0.000513	0.00137	CcSEcCtD
Diclofenamide—Vomiting—Goserelin—prostate cancer	0.000513	0.00137	CcSEcCtD
Diclofenamide—Constipation—Mitoxantrone—prostate cancer	0.000509	0.00136	CcSEcCtD
Diclofenamide—Rash—Goserelin—prostate cancer	0.000508	0.00135	CcSEcCtD
Diclofenamide—Vomiting—Conjugated Estrogens—prostate cancer	0.000508	0.00135	CcSEcCtD
Diclofenamide—Body temperature increased—Estradiol—prostate cancer	0.000505	0.00135	CcSEcCtD
Diclofenamide—Headache—Goserelin—prostate cancer	0.000505	0.00135	CcSEcCtD
Diclofenamide—Rash—Conjugated Estrogens—prostate cancer	0.000503	0.00134	CcSEcCtD
Diclofenamide—Headache—Conjugated Estrogens—prostate cancer	0.0005	0.00133	CcSEcCtD
Diclofenamide—Confusional state—Etoposide—prostate cancer	0.000499	0.00133	CcSEcCtD
Diclofenamide—Ataxia—Doxorubicin—prostate cancer	0.000491	0.00131	CcSEcCtD
Diclofenamide—Feeling abnormal—Mitoxantrone—prostate cancer	0.000491	0.00131	CcSEcCtD
Diclofenamide—Thrombocytopenia—Etoposide—prostate cancer	0.000485	0.00129	CcSEcCtD
Diclofenamide—Nausea—Goserelin—prostate cancer	0.000479	0.00128	CcSEcCtD
Diclofenamide—Hypokalaemia—Doxorubicin—prostate cancer	0.000476	0.00127	CcSEcCtD
Diclofenamide—Nausea—Conjugated Estrogens—prostate cancer	0.000474	0.00126	CcSEcCtD
Diclofenamide—Anorexia—Etoposide—prostate cancer	0.000472	0.00126	CcSEcCtD
Diclofenamide—Body temperature increased—Mitoxantrone—prostate cancer	0.000471	0.00125	CcSEcCtD
Diclofenamide—Asthenia—Estradiol—prostate cancer	0.000459	0.00122	CcSEcCtD
Diclofenamide—Tremor—Capecitabine—prostate cancer	0.000457	0.00122	CcSEcCtD
Diclofenamide—Pruritus—Estradiol—prostate cancer	0.000452	0.0012	CcSEcCtD
Diclofenamide—Leukopenia—Docetaxel—prostate cancer	0.000451	0.0012	CcSEcCtD
Diclofenamide—Pollakiuria—Epirubicin—prostate cancer	0.000451	0.0012	CcSEcCtD
Diclofenamide—Paraesthesia—Etoposide—prostate cancer	0.000445	0.00119	CcSEcCtD
Diclofenamide—Weight decreased—Epirubicin—prostate cancer	0.000442	0.00118	CcSEcCtD
Diclofenamide—Somnolence—Etoposide—prostate cancer	0.00044	0.00117	CcSEcCtD
Diclofenamide—Leukopenia—Capecitabine—prostate cancer	0.000437	0.00116	CcSEcCtD
Diclofenamide—Drowsiness—Epirubicin—prostate cancer	0.000435	0.00116	CcSEcCtD
Diclofenamide—Decreased appetite—Etoposide—prostate cancer	0.000431	0.00115	CcSEcCtD
Diclofenamide—Gastrointestinal disorder—Etoposide—prostate cancer	0.000428	0.00114	CcSEcCtD
Diclofenamide—Asthenia—Mitoxantrone—prostate cancer	0.000427	0.00114	CcSEcCtD
Diclofenamide—Fatigue—Etoposide—prostate cancer	0.000427	0.00114	CcSEcCtD
Diclofenamide—Constipation—Etoposide—prostate cancer	0.000424	0.00113	CcSEcCtD
Diclofenamide—Dizziness—Estradiol—prostate cancer	0.000423	0.00113	CcSEcCtD
Diclofenamide—Pollakiuria—Doxorubicin—prostate cancer	0.000417	0.00111	CcSEcCtD
Diclofenamide—Confusional state—Docetaxel—prostate cancer	0.000415	0.00111	CcSEcCtD
Diclofenamide—Weight decreased—Doxorubicin—prostate cancer	0.000409	0.00109	CcSEcCtD
Diclofenamide—Feeling abnormal—Etoposide—prostate cancer	0.000408	0.00109	CcSEcCtD
Diclofenamide—Vomiting—Estradiol—prostate cancer	0.000406	0.00108	CcSEcCtD
Diclofenamide—Agranulocytosis—Epirubicin—prostate cancer	0.000406	0.00108	CcSEcCtD
Diclofenamide—Thrombocytopenia—Docetaxel—prostate cancer	0.000403	0.00107	CcSEcCtD
Diclofenamide—Rash—Estradiol—prostate cancer	0.000403	0.00107	CcSEcCtD
Diclofenamide—Drowsiness—Doxorubicin—prostate cancer	0.000403	0.00107	CcSEcCtD
Diclofenamide—Confusional state—Capecitabine—prostate cancer	0.000402	0.00107	CcSEcCtD
Diclofenamide—Headache—Estradiol—prostate cancer	0.0004	0.00107	CcSEcCtD
Diclofenamide—Anorexia—Docetaxel—prostate cancer	0.000392	0.00105	CcSEcCtD
Diclofenamide—Body temperature increased—Etoposide—prostate cancer	0.000392	0.00104	CcSEcCtD
Diclofenamide—Thrombocytopenia—Capecitabine—prostate cancer	0.00039	0.00104	CcSEcCtD
Diclofenamide—Anorexia—Capecitabine—prostate cancer	0.00038	0.00101	CcSEcCtD
Diclofenamide—Nausea—Estradiol—prostate cancer	0.00038	0.00101	CcSEcCtD
Diclofenamide—Vomiting—Mitoxantrone—prostate cancer	0.000379	0.00101	CcSEcCtD
Diclofenamide—Agranulocytosis—Doxorubicin—prostate cancer	0.000376	0.001	CcSEcCtD
Diclofenamide—Rash—Mitoxantrone—prostate cancer	0.000375	0.001	CcSEcCtD
Diclofenamide—Headache—Mitoxantrone—prostate cancer	0.000373	0.000994	CcSEcCtD
Diclofenamide—Paraesthesia—Docetaxel—prostate cancer	0.00037	0.000985	CcSEcCtD
Diclofenamide—Somnolence—Docetaxel—prostate cancer	0.000366	0.000975	CcSEcCtD
Diclofenamide—Tinnitus—Epirubicin—prostate cancer	0.000364	0.000971	CcSEcCtD
Diclofenamide—Dyspepsia—Docetaxel—prostate cancer	0.000362	0.000966	CcSEcCtD
Diclofenamide—Paraesthesia—Capecitabine—prostate cancer	0.000358	0.000954	CcSEcCtD
Diclofenamide—Decreased appetite—Docetaxel—prostate cancer	0.000358	0.000954	CcSEcCtD
Diclofenamide—Gastrointestinal disorder—Docetaxel—prostate cancer	0.000355	0.000947	CcSEcCtD
Diclofenamide—Asthenia—Etoposide—prostate cancer	0.000355	0.000947	CcSEcCtD
Diclofenamide—Fatigue—Docetaxel—prostate cancer	0.000355	0.000946	CcSEcCtD
Diclofenamide—Nausea—Mitoxantrone—prostate cancer	0.000354	0.000943	CcSEcCtD
Diclofenamide—Constipation—Docetaxel—prostate cancer	0.000352	0.000938	CcSEcCtD
Diclofenamide—Dyspepsia—Capecitabine—prostate cancer	0.000351	0.000935	CcSEcCtD
Diclofenamide—Pruritus—Etoposide—prostate cancer	0.00035	0.000934	CcSEcCtD
Diclofenamide—Decreased appetite—Capecitabine—prostate cancer	0.000346	0.000923	CcSEcCtD
Diclofenamide—Gastrointestinal disorder—Capecitabine—prostate cancer	0.000344	0.000917	CcSEcCtD
Diclofenamide—Fatigue—Capecitabine—prostate cancer	0.000344	0.000916	CcSEcCtD
Diclofenamide—Constipation—Capecitabine—prostate cancer	0.000341	0.000908	CcSEcCtD
Diclofenamide—Feeling abnormal—Docetaxel—prostate cancer	0.000339	0.000904	CcSEcCtD
Diclofenamide—Anorexia—Prednisone—prostate cancer	0.000338	0.000902	CcSEcCtD
Diclofenamide—Tinnitus—Doxorubicin—prostate cancer	0.000337	0.000898	CcSEcCtD
Diclofenamide—Tension—Epirubicin—prostate cancer	0.000334	0.00089	CcSEcCtD
Diclofenamide—Nervousness—Epirubicin—prostate cancer	0.00033	0.000881	CcSEcCtD
Diclofenamide—Feeling abnormal—Capecitabine—prostate cancer	0.000328	0.000875	CcSEcCtD
Diclofenamide—Dizziness—Etoposide—prostate cancer	0.000328	0.000873	CcSEcCtD
Diclofenamide—Body temperature increased—Docetaxel—prostate cancer	0.000325	0.000867	CcSEcCtD
Diclofenamide—Paraesthesia—Prednisone—prostate cancer	0.000319	0.00085	CcSEcCtD
Diclofenamide—Body temperature increased—Capecitabine—prostate cancer	0.000315	0.00084	CcSEcCtD
Diclofenamide—Vomiting—Etoposide—prostate cancer	0.000315	0.000839	CcSEcCtD
Diclofenamide—Dyspepsia—Prednisone—prostate cancer	0.000312	0.000833	CcSEcCtD
Diclofenamide—Rash—Etoposide—prostate cancer	0.000312	0.000832	CcSEcCtD
Diclofenamide—Headache—Etoposide—prostate cancer	0.00031	0.000827	CcSEcCtD
Diclofenamide—Tension—Doxorubicin—prostate cancer	0.000309	0.000823	CcSEcCtD
Diclofenamide—Decreased appetite—Prednisone—prostate cancer	0.000309	0.000822	CcSEcCtD
Diclofenamide—Fatigue—Prednisone—prostate cancer	0.000306	0.000816	CcSEcCtD
Diclofenamide—Nervousness—Doxorubicin—prostate cancer	0.000306	0.000815	CcSEcCtD
Diclofenamide—Leukopenia—Epirubicin—prostate cancer	0.000305	0.000812	CcSEcCtD
Diclofenamide—Constipation—Prednisone—prostate cancer	0.000304	0.000809	CcSEcCtD
Diclofenamide—Asthenia—Docetaxel—prostate cancer	0.000295	0.000787	CcSEcCtD
Diclofenamide—Nausea—Etoposide—prostate cancer	0.000294	0.000784	CcSEcCtD
Diclofenamide—Feeling abnormal—Prednisone—prostate cancer	0.000293	0.00078	CcSEcCtD
Diclofenamide—Pruritus—Docetaxel—prostate cancer	0.000291	0.000776	CcSEcCtD
Diclofenamide—Asthenia—Capecitabine—prostate cancer	0.000286	0.000762	CcSEcCtD
Diclofenamide—Pruritus—Capecitabine—prostate cancer	0.000282	0.000751	CcSEcCtD
Diclofenamide—Leukopenia—Doxorubicin—prostate cancer	0.000282	0.000751	CcSEcCtD
Diclofenamide—Body temperature increased—Prednisone—prostate cancer	0.000281	0.000748	CcSEcCtD
Diclofenamide—Confusional state—Epirubicin—prostate cancer	0.00028	0.000746	CcSEcCtD
Diclofenamide—Dizziness—Docetaxel—prostate cancer	0.000272	0.000725	CcSEcCtD
Diclofenamide—Thrombocytopenia—Epirubicin—prostate cancer	0.000272	0.000724	CcSEcCtD
Diclofenamide—Anorexia—Epirubicin—prostate cancer	0.000265	0.000705	CcSEcCtD
Diclofenamide—Dizziness—Capecitabine—prostate cancer	0.000264	0.000702	CcSEcCtD
Diclofenamide—Vomiting—Docetaxel—prostate cancer	0.000262	0.000697	CcSEcCtD
Diclofenamide—Rash—Docetaxel—prostate cancer	0.00026	0.000692	CcSEcCtD
Diclofenamide—Confusional state—Doxorubicin—prostate cancer	0.000259	0.00069	CcSEcCtD
Diclofenamide—Headache—Docetaxel—prostate cancer	0.000258	0.000687	CcSEcCtD
Diclofenamide—Asthenia—Prednisone—prostate cancer	0.000255	0.000679	CcSEcCtD
Diclofenamide—Vomiting—Capecitabine—prostate cancer	0.000253	0.000675	CcSEcCtD
Diclofenamide—Thrombocytopenia—Doxorubicin—prostate cancer	0.000252	0.00067	CcSEcCtD
Diclofenamide—Rash—Capecitabine—prostate cancer	0.000251	0.00067	CcSEcCtD
Diclofenamide—Pruritus—Prednisone—prostate cancer	0.000251	0.000669	CcSEcCtD
Diclofenamide—Headache—Capecitabine—prostate cancer	0.00025	0.000665	CcSEcCtD
Diclofenamide—Paraesthesia—Epirubicin—prostate cancer	0.000249	0.000664	CcSEcCtD
Diclofenamide—Somnolence—Epirubicin—prostate cancer	0.000247	0.000658	CcSEcCtD
Diclofenamide—Anorexia—Doxorubicin—prostate cancer	0.000245	0.000653	CcSEcCtD
Diclofenamide—Nausea—Docetaxel—prostate cancer	0.000244	0.000652	CcSEcCtD
Diclofenamide—Dyspepsia—Epirubicin—prostate cancer	0.000244	0.000651	CcSEcCtD
Diclofenamide—Decreased appetite—Epirubicin—prostate cancer	0.000241	0.000643	CcSEcCtD
Diclofenamide—Gastrointestinal disorder—Epirubicin—prostate cancer	0.00024	0.000639	CcSEcCtD
Diclofenamide—Fatigue—Epirubicin—prostate cancer	0.000239	0.000638	CcSEcCtD
Diclofenamide—Constipation—Epirubicin—prostate cancer	0.000237	0.000633	CcSEcCtD
Diclofenamide—Nausea—Capecitabine—prostate cancer	0.000237	0.000631	CcSEcCtD
Diclofenamide—Dizziness—Prednisone—prostate cancer	0.000235	0.000626	CcSEcCtD
Diclofenamide—Paraesthesia—Doxorubicin—prostate cancer	0.000231	0.000615	CcSEcCtD
Diclofenamide—Feeling abnormal—Epirubicin—prostate cancer	0.000229	0.00061	CcSEcCtD
Diclofenamide—Somnolence—Doxorubicin—prostate cancer	0.000228	0.000609	CcSEcCtD
Diclofenamide—Dyspepsia—Doxorubicin—prostate cancer	0.000226	0.000603	CcSEcCtD
Diclofenamide—Vomiting—Prednisone—prostate cancer	0.000226	0.000602	CcSEcCtD
Diclofenamide—Rash—Prednisone—prostate cancer	0.000224	0.000597	CcSEcCtD
Diclofenamide—Decreased appetite—Doxorubicin—prostate cancer	0.000223	0.000595	CcSEcCtD
Diclofenamide—Headache—Prednisone—prostate cancer	0.000222	0.000593	CcSEcCtD
Diclofenamide—Gastrointestinal disorder—Doxorubicin—prostate cancer	0.000222	0.000591	CcSEcCtD
Diclofenamide—Fatigue—Doxorubicin—prostate cancer	0.000221	0.00059	CcSEcCtD
Diclofenamide—Constipation—Doxorubicin—prostate cancer	0.00022	0.000585	CcSEcCtD
Diclofenamide—Body temperature increased—Epirubicin—prostate cancer	0.000219	0.000585	CcSEcCtD
Diclofenamide—Feeling abnormal—Doxorubicin—prostate cancer	0.000212	0.000564	CcSEcCtD
Diclofenamide—Nausea—Prednisone—prostate cancer	0.000211	0.000562	CcSEcCtD
Diclofenamide—Body temperature increased—Doxorubicin—prostate cancer	0.000203	0.000541	CcSEcCtD
Diclofenamide—Asthenia—Epirubicin—prostate cancer	0.000199	0.000531	CcSEcCtD
Diclofenamide—Pruritus—Epirubicin—prostate cancer	0.000196	0.000523	CcSEcCtD
Diclofenamide—Asthenia—Doxorubicin—prostate cancer	0.000184	0.000491	CcSEcCtD
Diclofenamide—Dizziness—Epirubicin—prostate cancer	0.000184	0.000489	CcSEcCtD
Diclofenamide—Pruritus—Doxorubicin—prostate cancer	0.000182	0.000484	CcSEcCtD
Diclofenamide—Vomiting—Epirubicin—prostate cancer	0.000177	0.00047	CcSEcCtD
Diclofenamide—Rash—Epirubicin—prostate cancer	0.000175	0.000467	CcSEcCtD
Diclofenamide—Headache—Epirubicin—prostate cancer	0.000174	0.000464	CcSEcCtD
Diclofenamide—Dizziness—Doxorubicin—prostate cancer	0.00017	0.000453	CcSEcCtD
Diclofenamide—Nausea—Epirubicin—prostate cancer	0.000165	0.00044	CcSEcCtD
Diclofenamide—Vomiting—Doxorubicin—prostate cancer	0.000163	0.000435	CcSEcCtD
Diclofenamide—Rash—Doxorubicin—prostate cancer	0.000162	0.000432	CcSEcCtD
Diclofenamide—Headache—Doxorubicin—prostate cancer	0.000161	0.000429	CcSEcCtD
Diclofenamide—Nausea—Doxorubicin—prostate cancer	0.000153	0.000407	CcSEcCtD
Diclofenamide—CA1—Metabolism—TYMS—prostate cancer	4.6e-05	0.00021	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—ADI1—prostate cancer	4.55e-05	0.000208	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—TST—prostate cancer	4.55e-05	0.000208	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—PSAT1—prostate cancer	4.55e-05	0.000208	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—CBR1—prostate cancer	4.55e-05	0.000208	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—CSAD—prostate cancer	4.55e-05	0.000208	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—GRHL1—prostate cancer	4.55e-05	0.000208	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—GSTM1—prostate cancer	4.55e-05	0.000207	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—RXRA—prostate cancer	4.54e-05	0.000207	CbGpPWpGaD
Diclofenamide—CA14—Metabolism—NOS3—prostate cancer	4.54e-05	0.000207	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—CYP1A1—prostate cancer	4.5e-05	0.000205	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—LPL—prostate cancer	4.47e-05	0.000204	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—ERCC2—prostate cancer	4.46e-05	0.000203	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—LRP2—prostate cancer	4.45e-05	0.000203	CbGpPWpGaD
Diclofenamide—CA6—Metabolism—NOS3—prostate cancer	4.42e-05	0.000202	CbGpPWpGaD
Diclofenamide—CA5A—Metabolism—NOS3—prostate cancer	4.42e-05	0.000202	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—MTHFR—prostate cancer	4.37e-05	0.000199	CbGpPWpGaD
Diclofenamide—CA5B—Metabolism—PIK3CD—prostate cancer	4.37e-05	0.000199	CbGpPWpGaD
Diclofenamide—CA7—Metabolism—PIK3CD—prostate cancer	4.37e-05	0.000199	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—COMT—prostate cancer	4.37e-05	0.000199	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—P4HB—prostate cancer	4.36e-05	0.000199	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—INS—prostate cancer	4.36e-05	0.000199	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—GSTP1—prostate cancer	4.35e-05	0.000198	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—CYP1A1—prostate cancer	4.31e-05	0.000197	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—PPARA—prostate cancer	4.29e-05	0.000196	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—ITPR1—prostate cancer	4.28e-05	0.000195	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—ERCC2—prostate cancer	4.28e-05	0.000195	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—CREBBP—prostate cancer	4.27e-05	0.000195	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—CKMT2—prostate cancer	4.23e-05	0.000193	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—UGT2B17—prostate cancer	4.23e-05	0.000193	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—GRHPR—prostate cancer	4.23e-05	0.000193	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—UGT2B15—prostate cancer	4.23e-05	0.000193	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—MTHFR—prostate cancer	4.19e-05	0.000191	CbGpPWpGaD
Diclofenamide—CA14—Metabolism—PIK3CB—prostate cancer	4.19e-05	0.000191	CbGpPWpGaD
Diclofenamide—CA14—Metabolism—PTGS2—prostate cancer	4.15e-05	0.000189	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—SULT2A1—prostate cancer	4.14e-05	0.000189	CbGpPWpGaD
Diclofenamide—CA5B—Metabolism—NOS3—prostate cancer	4.13e-05	0.000188	CbGpPWpGaD
Diclofenamide—CA7—Metabolism—NOS3—prostate cancer	4.13e-05	0.000188	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—PPARA—prostate cancer	4.11e-05	0.000188	CbGpPWpGaD
Diclofenamide—CA5A—Metabolism—PIK3CB—prostate cancer	4.08e-05	0.000186	CbGpPWpGaD
Diclofenamide—CA6—Metabolism—PIK3CB—prostate cancer	4.08e-05	0.000186	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—MED12—prostate cancer	4.07e-05	0.000186	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—PIK3CD—prostate cancer	4.05e-05	0.000185	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—TYMS—prostate cancer	4.05e-05	0.000184	CbGpPWpGaD
Diclofenamide—CA5A—Metabolism—PTGS2—prostate cancer	4.05e-05	0.000184	CbGpPWpGaD
Diclofenamide—CA6—Metabolism—PTGS2—prostate cancer	4.05e-05	0.000184	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—CAV1—prostate cancer	4.03e-05	0.000184	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—MTHFR—prostate cancer	4.02e-05	0.000183	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—GSTM1—prostate cancer	4e-05	0.000182	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—AOX1—prostate cancer	3.98e-05	0.000181	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—MBTPS1—prostate cancer	3.98e-05	0.000181	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—PGAM2—prostate cancer	3.98e-05	0.000181	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—GSTM3—prostate cancer	3.98e-05	0.000181	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—SULT2B1—prostate cancer	3.98e-05	0.000181	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—NAGLU—prostate cancer	3.98e-05	0.000181	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—RFK—prostate cancer	3.98e-05	0.000181	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—PPARA—prostate cancer	3.94e-05	0.00018	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—LPL—prostate cancer	3.93e-05	0.000179	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—NCOA3—prostate cancer	3.89e-05	0.000177	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—CAV1—prostate cancer	3.87e-05	0.000176	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—NOS3—prostate cancer	3.83e-05	0.000174	CbGpPWpGaD
Diclofenamide—CA7—Metabolism—PIK3CB—prostate cancer	3.81e-05	0.000174	CbGpPWpGaD
Diclofenamide—CA5B—Metabolism—PIK3CB—prostate cancer	3.81e-05	0.000174	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—CYP1A1—prostate cancer	3.79e-05	0.000173	CbGpPWpGaD
Diclofenamide—CA7—Metabolism—PTGS2—prostate cancer	3.78e-05	0.000172	CbGpPWpGaD
Diclofenamide—CA5B—Metabolism—PTGS2—prostate cancer	3.78e-05	0.000172	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—DEGS1—prostate cancer	3.77e-05	0.000172	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—CYP3A43—prostate cancer	3.77e-05	0.000172	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—AMACR—prostate cancer	3.77e-05	0.000172	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—NAT1—prostate cancer	3.77e-05	0.000172	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—SRD5A2—prostate cancer	3.77e-05	0.000172	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—ERCC2—prostate cancer	3.76e-05	0.000171	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—prostate cancer	3.71e-05	0.000169	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—CAV1—prostate cancer	3.71e-05	0.000169	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP2C19—prostate cancer	3.69e-05	0.000168	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—PIK3CG—prostate cancer	3.68e-05	0.000168	CbGpPWpGaD
Diclofenamide—CA14—Metabolism—PTEN—prostate cancer	3.62e-05	0.000165	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—HSD17B1—prostate cancer	3.6e-05	0.000164	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—ACHE—prostate cancer	3.6e-05	0.000164	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—MTHFR—prostate cancer	3.53e-05	0.000161	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—PIK3CB—prostate cancer	3.53e-05	0.000161	CbGpPWpGaD
Diclofenamide—CA6—Metabolism—PTEN—prostate cancer	3.53e-05	0.000161	CbGpPWpGaD
Diclofenamide—CA5A—Metabolism—PTEN—prostate cancer	3.53e-05	0.000161	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—PIK3CG—prostate cancer	3.52e-05	0.000161	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—PTGS2—prostate cancer	3.5e-05	0.00016	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—INS—prostate cancer	3.48e-05	0.000159	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—PPARA—prostate cancer	3.47e-05	0.000158	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C3—prostate cancer	3.46e-05	0.000158	CbGpPWpGaD
Diclofenamide—CA14—Metabolism—EP300—prostate cancer	3.45e-05	0.000157	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—PRKACB—prostate cancer	3.44e-05	0.000157	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—CREBBP—prostate cancer	3.41e-05	0.000155	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP17A1—prostate cancer	3.41e-05	0.000155	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—PIK3CG—prostate cancer	3.38e-05	0.000154	CbGpPWpGaD
Diclofenamide—CA6—Metabolism—EP300—prostate cancer	3.36e-05	0.000153	CbGpPWpGaD
Diclofenamide—CA5A—Metabolism—EP300—prostate cancer	3.36e-05	0.000153	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—INS—prostate cancer	3.34e-05	0.000152	CbGpPWpGaD
Diclofenamide—CA5B—Metabolism—PTEN—prostate cancer	3.29e-05	0.00015	CbGpPWpGaD
Diclofenamide—CA7—Metabolism—PTEN—prostate cancer	3.29e-05	0.00015	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—CREBBP—prostate cancer	3.27e-05	0.000149	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—CAV1—prostate cancer	3.26e-05	0.000149	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—NCOA2—prostate cancer	3.25e-05	0.000148	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—PIK3CD—prostate cancer	3.23e-05	0.000147	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—HPGD—prostate cancer	3.21e-05	0.000146	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—B4GALT4—prostate cancer	3.21e-05	0.000146	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—INS—prostate cancer	3.2e-05	0.000146	CbGpPWpGaD
Diclofenamide—CA5B—Metabolism—EP300—prostate cancer	3.14e-05	0.000143	CbGpPWpGaD
Diclofenamide—CA7—Metabolism—EP300—prostate cancer	3.14e-05	0.000143	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—CREBBP—prostate cancer	3.13e-05	0.000143	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—PIK3CD—prostate cancer	3.1e-05	0.000141	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—PTEN—prostate cancer	3.05e-05	0.000139	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—NOS3—prostate cancer	3.05e-05	0.000139	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—TNFRSF21—prostate cancer	3.02e-05	0.000138	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—PIK3CG—prostate cancer	2.97e-05	0.000135	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—PIK3CD—prostate cancer	2.97e-05	0.000135	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—MTAP—prostate cancer	2.93e-05	0.000134	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—CYP7B1—prostate cancer	2.93e-05	0.000134	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—NOS3—prostate cancer	2.92e-05	0.000133	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—EP300—prostate cancer	2.91e-05	0.000133	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—prostate cancer	2.87e-05	0.000131	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—SRD5A1—prostate cancer	2.86e-05	0.00013	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—SULT1E1—prostate cancer	2.86e-05	0.00013	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—PIK3CB—prostate cancer	2.82e-05	0.000128	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—INS—prostate cancer	2.81e-05	0.000128	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—NOS3—prostate cancer	2.8e-05	0.000128	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—PTGS2—prostate cancer	2.79e-05	0.000127	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—prostate cancer	2.78e-05	0.000127	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—CREBBP—prostate cancer	2.75e-05	0.000126	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—NCOA1—prostate cancer	2.74e-05	0.000125	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—ACSL4—prostate cancer	2.73e-05	0.000124	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—HSD17B3—prostate cancer	2.73e-05	0.000124	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—PIK3CB—prostate cancer	2.7e-05	0.000123	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—prostate cancer	2.7e-05	0.000123	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—PTGS2—prostate cancer	2.68e-05	0.000122	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—UMPS—prostate cancer	2.61e-05	0.000119	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—ARG2—prostate cancer	2.61e-05	0.000119	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—PHGDH—prostate cancer	2.61e-05	0.000119	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—PIK3CD—prostate cancer	2.61e-05	0.000119	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—RXRA—prostate cancer	2.6e-05	0.000119	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—PIK3CB—prostate cancer	2.59e-05	0.000118	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—PTGS2—prostate cancer	2.56e-05	0.000117	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—LDHB—prostate cancer	2.56e-05	0.000117	CbGpPWpGaD
Diclofenamide—CA14—Metabolism—PIK3CA—prostate cancer	2.55e-05	0.000116	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—CYP3A5—prostate cancer	2.52e-05	0.000115	CbGpPWpGaD
Diclofenamide—CA6—Metabolism—PIK3CA—prostate cancer	2.49e-05	0.000113	CbGpPWpGaD
Diclofenamide—CA5A—Metabolism—PIK3CA—prostate cancer	2.49e-05	0.000113	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—NOS3—prostate cancer	2.47e-05	0.000112	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—PTEN—prostate cancer	2.43e-05	0.000111	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—UCP3—prostate cancer	2.43e-05	0.000111	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—TCN2—prostate cancer	2.43e-05	0.000111	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—PDHA1—prostate cancer	2.43e-05	0.000111	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—GSTA3—prostate cancer	2.43e-05	0.000111	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—PTEN—prostate cancer	2.33e-05	0.000106	CbGpPWpGaD
Diclofenamide—CA7—Metabolism—PIK3CA—prostate cancer	2.32e-05	0.000106	CbGpPWpGaD
Diclofenamide—CA5B—Metabolism—PIK3CA—prostate cancer	2.32e-05	0.000106	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—EP300—prostate cancer	2.32e-05	0.000106	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—HSD3B1—prostate cancer	2.32e-05	0.000106	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—SLC22A3—prostate cancer	2.32e-05	0.000106	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—PIK3CB—prostate cancer	2.28e-05	0.000104	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—PTGS2—prostate cancer	2.25e-05	0.000103	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—LPL—prostate cancer	2.25e-05	0.000103	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—PTEN—prostate cancer	2.24e-05	0.000102	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—EP300—prostate cancer	2.22e-05	0.000101	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—GSTA4—prostate cancer	2.22e-05	0.000101	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—TBXAS1—prostate cancer	2.22e-05	0.000101	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—prostate cancer	2.17e-05	9.91e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—GSTA2—prostate cancer	2.17e-05	9.88e-05	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—PIK3CA—prostate cancer	2.15e-05	9.82e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—SULT1A1—prostate cancer	2.14e-05	9.76e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—ABCG5—prostate cancer	2.14e-05	9.76e-05	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—EP300—prostate cancer	2.13e-05	9.73e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—GSTA1—prostate cancer	2.09e-05	9.53e-05	CbGpPWpGaD
Diclofenamide—CA14—Metabolism—AKT1—prostate cancer	2.09e-05	9.51e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—NAT2—prostate cancer	2.07e-05	9.43e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—HSD3B2—prostate cancer	2.07e-05	9.43e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—GSTO1—prostate cancer	2.07e-05	9.43e-05	CbGpPWpGaD
Diclofenamide—CA5A—Metabolism—AKT1—prostate cancer	2.03e-05	9.27e-05	CbGpPWpGaD
Diclofenamide—CA6—Metabolism—AKT1—prostate cancer	2.03e-05	9.27e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	1.99e-05	9.06e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—CYP2C18—prostate cancer	1.98e-05	9.04e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—PLCB2—prostate cancer	1.98e-05	9.04e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—LRP2—prostate cancer	1.98e-05	9.04e-05	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—PTEN—prostate cancer	1.97e-05	8.97e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—P4HB—prostate cancer	1.94e-05	8.86e-05	CbGpPWpGaD
Diclofenamide—CA7—Metabolism—AKT1—prostate cancer	1.9e-05	8.66e-05	CbGpPWpGaD
Diclofenamide—CA5B—Metabolism—AKT1—prostate cancer	1.9e-05	8.66e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—SLC22A1—prostate cancer	1.89e-05	8.62e-05	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—EP300—prostate cancer	1.88e-05	8.55e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	1.87e-05	8.52e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—SULT2A1—prostate cancer	1.84e-05	8.4e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—MED12—prostate cancer	1.81e-05	8.26e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—GNG5—prostate cancer	1.8e-05	8.2e-05	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—AKT1—prostate cancer	1.76e-05	8.02e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—NCOA3—prostate cancer	1.73e-05	7.9e-05	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—PIK3CA—prostate cancer	1.72e-05	7.83e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	1.7e-05	7.76e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—HPGDS—prostate cancer	1.65e-05	7.54e-05	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—PIK3CA—prostate cancer	1.65e-05	7.5e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—CYP2C19—prostate cancer	1.64e-05	7.49e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—GSTT1—prostate cancer	1.6e-05	7.31e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—ACHE—prostate cancer	1.6e-05	7.31e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—CYP2A6—prostate cancer	1.58e-05	7.22e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	1.58e-05	7.2e-05	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—PIK3CA—prostate cancer	1.58e-05	7.2e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—AKR1C3—prostate cancer	1.54e-05	7.03e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—PRKACB—prostate cancer	1.53e-05	6.99e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—CYP17A1—prostate cancer	1.52e-05	6.92e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	1.5e-05	6.82e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—NCOA2—prostate cancer	1.45e-05	6.59e-05	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—AKT1—prostate cancer	1.4e-05	6.39e-05	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—PIK3CA—prostate cancer	1.39e-05	6.33e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—SLC5A5—prostate cancer	1.38e-05	6.29e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—CYP2E1—prostate cancer	1.35e-05	6.14e-05	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—AKT1—prostate cancer	1.34e-05	6.13e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—NQO1—prostate cancer	1.33e-05	6.07e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—TH—prostate cancer	1.31e-05	5.99e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	1.3e-05	5.95e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—CYP3A4—prostate cancer	1.3e-05	5.92e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	1.29e-05	5.89e-05	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—AKT1—prostate cancer	1.29e-05	5.88e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—CYP1B1—prostate cancer	1.28e-05	5.82e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—GGT1—prostate cancer	1.24e-05	5.64e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—NCOA1—prostate cancer	1.22e-05	5.56e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—CYP19A1—prostate cancer	1.2e-05	5.47e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—RXRA—prostate cancer	1.16e-05	5.28e-05	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—AKT1—prostate cancer	1.13e-05	5.17e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	1.13e-05	5.14e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—COMT—prostate cancer	1.12e-05	5.09e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—GSTP1—prostate cancer	1.11e-05	5.07e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—ITPR1—prostate cancer	1.09e-05	4.98e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—EP300—prostate cancer	1.07e-05	4.9e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—TYMS—prostate cancer	1.03e-05	4.71e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—GSTM1—prostate cancer	1.02e-05	4.66e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—LPL—prostate cancer	1e-05	4.57e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—CYP1A1—prostate cancer	9.68e-06	4.41e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—ERCC2—prostate cancer	9.6e-06	4.38e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—MTHFR—prostate cancer	9.02e-06	4.11e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—PPARA—prostate cancer	8.85e-06	4.04e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—CAV1—prostate cancer	8.32e-06	3.79e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	7.95e-06	3.63e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—PIK3CG—prostate cancer	7.58e-06	3.46e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—INS—prostate cancer	7.18e-06	3.27e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—CREBBP—prostate cancer	7.03e-06	3.2e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—PIK3CD—prostate cancer	6.66e-06	3.04e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—NOS3—prostate cancer	6.29e-06	2.87e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—PIK3CB—prostate cancer	5.81e-06	2.65e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—PTGS2—prostate cancer	5.76e-06	2.62e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—PTEN—prostate cancer	5.02e-06	2.29e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—EP300—prostate cancer	4.79e-06	2.18e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—PIK3CA—prostate cancer	3.54e-06	1.61e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—AKT1—prostate cancer	2.89e-06	1.32e-05	CbGpPWpGaD
